Pertuzumab Plus High-Dose Trastuzumab for HER2-Positive Breast Cancer With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data
NPJ Breast Cancer 2023 Nov 17;9(1)94, NU Lin, P Kumthekar, S Sahebjam, N Ibrahim, A Fung, A Cheng, A Nicholas, J Sussell, M PegramFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.